Almagate
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| ATC code | |
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | Al2Mg6(OH)14(CO3)2 · 4 H2O |
| Molar mass | 314.99 g/mol |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Almagate (trade name Almax) is an aluminium- and magnesium-containing antacid. It was first described in 1984.[1][2]
Adverse effects
Almagate is well tolerated. In a clinical trial, the most common adverse effects were diarrhea and nausea.[3]
References
- ^ Moragues, J. B. (1984). "Characterization of a new crystalline synthetic gastric antacid, almagate" (Free full text). Arzneimittel-Forschung. 34 (10A): 1346–1349. ISSN 0004-4172. PMID 6548918.
{{cite journal}}: Cite has empty unknown parameter:|month=(help) - ^ Beneyto, J. F. B. (1984). "Evaluation of a new antacid, almagate" (Free full text). Arzneimittel-Forschung. 34 (10A): 1350–1354. ISSN 0004-4172. PMID 6439224.
{{cite journal}}: Cite has empty unknown parameter:|month=(help) - ^ Suau, A. D.; Dominguez Martin, A; Ferrando Cucarella, J; Juncosa Iglesias, L; Muñoz Benitez, J; Nieto Calvet, M; Pérez Gieb, J; Pérez Mota, A; Pineda Garcia, A; Rodriguez Sanchez, E (1984). "Treatment of gastric pyrosis with almagate in patients with and without endoscopically demonstrable duodenal ulcer. A multicentre clinical trial" (Free full text). Arzneimittel-Forschung. 34 (10A): 1380–1383. ISSN 0004-4172. PMID 6548926.
{{cite journal}}: Cite has empty unknown parameter:|month=(help)
 | This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |